Global Bioactive Peptides Market – Industry Trends and Forecast to 2030

Bioactive Peptides Market Analysis and Size

The essential factors contributing to the growth of global bioactive peptides market in the forecast period of 2023 to 2020 include growing demand for functional foods and nutraceuticals. The rise in aging population and health concerns along with technological advancements in peptide synthesis and extraction accelerate the global bioactive peptides market growth.

Data Bridge Market Research analyses that the global bioactive peptides market which was USD 4,960.47 million in 2022, is expected to reach USD 10,710.79 million by 2030, growing at a CAGR of 10.10% during the forecast period of 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Bioactive Peptides Market Scope and Segmentation

Market Definition

Bioactive peptides are the amino acids joined together in a covalent bond; these substances are extracted from various natural sources providing a variety of health benefits. They are also used in providing various functioning for food and beverage products resulting in less oxidation and degradation.

Global Bioactive Peptides Market Dynamics

Drivers

• Growing Demand for Functional Foods and Nutraceuticals

Functional foods and nutraceuticals are gaining popularity as consumers look for products that can provide health benefits beyond basic nutrition. Bioactive peptides are used as ingredients in functional foods and nutraceuticals due to their physiological effects. The increasing demand for these products is driving the global market for bioactive peptides.

• Increasing Aging Population and Health Concerns

The global population is aging, leading to an increased prevalence of age-related health issues such as cardiovascular diseases, osteoporosis, and cognitive decline. Bioactive peptides have shown potential in managing and preventing these health conditions, leading to their increased demand among the aging population.

Opportunity

• Technological Advancements in Peptide Synthesis and Extraction

Advances in technology have made it easier and more cost-effective to synthesize and extract bioactive peptides. Innovative techniques, such as enzymatic hydrolysis, microbial fermentation, and bioinformatics tools, have improved the production efficiency of bioactive peptides. These technological advancements have contributed to the growth of the global market.

Restraint/Challenge

• High Production Cost

The production of bioactive peptides can be complex and costly, especially when advanced technologies and specialized equipment are required. The cost of raw materials, extraction processes, and purification methods can contribute to higher production costs, which may limit the market's growth.

This global bioactive peptides market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global bioactive peptides market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions. Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Development

• In January 2022, BASF SE launched Peptovitae, which is a series of four patented peptides that represent a new generation of scientifically developed biomimetic peptides. Peptovitae has been developed in Asia through an exclusive relationship with Caregen, a Korean-based company and global leader in biomimetic peptide research and development

Global Bioactive Peptides Market Scope

The global bioactive peptides market is segmented on the basis of source, therapeutic area, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

• Plant
• Milk
• Eggs
• Meat
• Fish
• Others

Therapeutic Area

• Anti-Hypertensives
• Cardiovascular System
• Nervous System
• Gastrointestinal System
• Antioxidant
• Immunostimulatory
• Antimicrobial
• Diabetes
• Immune System

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Drug Store
• Mail-Order Pharmacy

Global Bioactive Peptides Market Regional Analysis/Insights

The global bioactive peptides market is analyzed and market size insights and trends are provided by country, source, therapeutic area, and distribution channel as referenced above.

The countries covered in the global bioactive peptides market report are  U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa

North America leads the global bioactive peptides market because of the presence of dominant players and high acceptance of bioactive peptides in U.S.

Asia-Pacific on the other hand, is estimated to show lucrative growth in the global bioactive peptides market over the forecast period of 2023-2030, owing to the rise in the demand for healthy diets and increase in cost-effective alternatives.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Bioactive Peptides Market Share Analysis

The global bioactive peptides market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to conducting global bioactive peptides  market.

Some of the major players operating in the global bioactive peptides market are:

• Seagarden AS (Norway)
• Arlak Biotech Pvt. Ltd. (India)
• Phermpep Co. Ltd. (South Korea)
• Naturade (U.S.)
• Creative Peptides (U.S.)
• Ingredia Nutritional (France)
• GELITA AG (Germany)
• PolyPeptide Group (U.S.)
• Creative-Biolabs (U.S.)
• Peptan (France)
• ADM (U.S.)
• DSM (Netherlands)
• Valio Ltd. (Finland)
• Kerry (Ireland)
• DuPont (U.S.)
• BASF SE (Germany)

SKU-40904